These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29683)

  • 1. Dopamine and its relation to schizophrenia and antipsychotic drugs.
    Tarnoff GM
    Bull Menninger Clin; 1978 Jul; 42(4):321-38. PubMed ID: 29683
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 5. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopaminergic receptor activity and the evolution of schizophrenia].
    Fodoreanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
    [No Abstract]   [Full Text] [Related]  

  • 8. Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication.
    Crow TJ; Cross AJ; Johnstone EC; Longden A; Owen F; Ridley RM
    Adv Biochem Psychopharmacol; 1980; 24():495-503. PubMed ID: 6105795
    [No Abstract]   [Full Text] [Related]  

  • 9. Schizophrenia.
    Morrison PD; Murray RM
    Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
    [No Abstract]   [Full Text] [Related]  

  • 10. [The optimal level of dopaminergic neurotransmission].
    de Haan L
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1721-2. PubMed ID: 16114285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic aspects of schizophrenia.
    Tandon R
    Br J Psychiatry Suppl; 1999; (37):7-11. PubMed ID: 10211133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 13. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
    Meltzer HY
    Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenia drug says goodbye to dopamine.
    Weinberger DR
    Nat Med; 2007 Sep; 13(9):1018-9. PubMed ID: 17828217
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurobiology in the neuropharmacology of antipsychotic drugs].
    Tassin JP
    Encephale; 2006 Jan; 32 Pt 2():S6-7. PubMed ID: 16800077
    [No Abstract]   [Full Text] [Related]  

  • 18. The co-occurrence of schizophrenia and alcoholism: comments on Michael Soyka's editorial.
    Heinz A; Mann K
    Addiction; 2000 Dec; 95(12):1863-4. PubMed ID: 11218364
    [No Abstract]   [Full Text] [Related]  

  • 19. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.